Manufacturers/Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.

3 drugs in NADAC|0 Generic,3 Brand

Neurocrine Biosciences, Inc. lists 3 NDCs in the CMS NADAC file (0 generic, 3 brand), at an average NADAC of $284.74 per unit, with a week-over-week move of +3.5% across products that moved. The firm's full portfolio, pricing trend are listed below.

Total Drugs

3

0G / 3B

Avg Price / Unit

$284.7389

$270.59 – $291.82

Avg 7d Change

+3.50%

Across 3 drugs with changes

7d Activity

3↑0 flat

of 3 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Keep following this manufacturer

These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.

Frequently Asked Questions

How many drugs does Neurocrine Biosciences, Inc. make?

Neurocrine Biosciences, Inc. lists 3 NDCs in the CMS NADAC file — 0 generic and 3 brand products.

What is the average price of Neurocrine Biosciences, Inc. drugs?

The average NADAC across Neurocrine Biosciences, Inc.'s portfolio is $284.7389 per unit, ranging from $270.5863 to $291.8152.

What types of drugs does Neurocrine Biosciences, Inc. make?

Neurocrine Biosciences, Inc. makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Vesicular Monoamine Transporter 2 Inhibitor (3).

Has Neurocrine Biosciences, Inc. had any drug recalls?

No FDA enforcement recalls are matched to Neurocrine Biosciences, Inc. in the openFDA feed.

How has Neurocrine Biosciences, Inc.'s pricing changed recently?

Over the past 7 days, 3 Neurocrine Biosciences, Inc. products rose and 0 fell, with a portfolio-wide average change of +3.5%.

Drug Portfolio

3 drugs total, 3 shown

WatchDrug ↕Price 7d Change ↕
INGREZZA 60 MG CAPSULE
Valbenazine
$291.8152
per EA
+3.00%
INGREZZA 80 MG CAPSULE
Valbenazine
$291.8152
per EA
+3.00%
INGREZZA 40 MG CAPSULE
Valbenazine
$270.5863
per EA
+4.50%